Iwasaki H, Aoyama H, Ueda T, Uchida M, Nakamura T
First Department of Internal Medicine, Fukui Medical School, Japan.
Anticancer Res. 1992 May-Jun;12(3):941-7.
To compare the morphologic differences in leukemic cells exposed to a nucleotide synthesis inhibitor and a DNA strand damage inducer, L1210 cells incubated with 1-beta-D-arabinofuranosylcytosine (ara-C) or daunorubicin (DNR) were investigated by time-lapse video microscopy, flow cytometry and transmission electron microscopy. At 1.0 microgram/ml of ara-C, cells could be separated into two populations, with some becoming ballooned and deformed, i.e. irreversibly damaged, and others remaining unchanged, i.e. in a proliferative state. In contrast, at 0.10 microgram/ml of DNR, nearly all cells were remarkably enlarged and did not proliferate during 72 hours of observation. Such morphologic changes induced at clinically achievable concentrations of each agent seemed to reflect their differing mechanisms of action on the synthesis of DNA. The methods described may allow the characterization of antileukemic agents as well as the development of clinical designs for their rational application in leukemia patients.
为比较暴露于核苷酸合成抑制剂和DNA链损伤诱导剂的白血病细胞的形态学差异,通过延时视频显微镜、流式细胞术和透射电子显微镜对用1-β-D-阿拉伯呋喃糖基胞嘧啶(阿糖胞苷)或柔红霉素(DNR)孵育的L1210细胞进行了研究。在1.0微克/毫升阿糖胞苷作用下,细胞可分为两个群体,一些细胞变得肿胀变形,即发生不可逆损伤,而另一些细胞保持不变,即处于增殖状态。相比之下,在0.10微克/毫升柔红霉素作用下,几乎所有细胞在72小时观察期内均显著增大且不增殖。每种药物在临床可达到浓度下诱导的这种形态学变化似乎反映了它们对DNA合成的不同作用机制。所述方法可能有助于对抗白血病药物进行表征,并为其在白血病患者中的合理应用制定临床方案。